An innovative study has uncovered two genes that promote the formation of prostate tumours. Both genes activate a signalling pathway that plays a part in the growth, division and death of cells and is ...

The goal of our laboratory is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma, three paediatric solid tumours in which high-risk patient ...

Ovarian cancer continues to claim thousands of lives in the UK each year, despite being relatively treatable if it’s caught early. However, an innovative laboratory test – the liquid biopsy – could ...

What is the study about? SPRUCE is investigating different ways of collecting questionnaires from our trial participants. People taking part in clinical trials are often asked to complete ...

Dr Gabriela Kramer-Marek’s group uses cutting-edge biomedical imaging techniques to gain information about the way particular genes drive cancer progression. Our group’s long-term goal is to develop ...

Our group's aim is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma. The goal of our laboratory is to improve the treatment and survival of ...

The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend that the targeted drug olaparib can be used for locally advanced or metastatic breast cancer. The ...

Yildiz joined the ICR in September 2024 as a postdoctoral training fellow. Previously she completed her MPharm degree at Istanbul University, followed by an MSc degree in Organic Chemistry at the ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research published in ...

Cell Division Jon Pines Why do cells always destroy cyclin A before cyclin B?”. Cyclin A has protein interaction motifs to ensure that it is degraded as soon as cells enter mitosis. We have used ...